What is Joint's operating income?

Joint's total operating income in 2025 was -$913.38 thousand, based on the following breakdown: Total Gross Profit: $43.67 million Total Operating Expenses: $44.58 million

Joint (JYNT) Financials

$6.91 +0.01 (+0.14%)

Closing price 04:00 PM Eastern

Extended Trading

$6.91 0.00 (0.00%)

As of 04:04 PM Eastern

Compare

Annual Income Statements for Joint

This table shows Joint's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Net Income / (Loss) Attributable to Common Shareholders	-8.80	-15	18	0.15	3.32	13	7.57	-7.53	-9.75	-5.80	2.91
Consolidated Net Income / (Loss)	-8.80	-15	-3.43	0.15	3.32	13	7.57	-5.80	-9.75	-5.80	2.91
Net Income / (Loss) Continuing Operations	-8.80	-15	18	0.15	3.32	13	7.57	-1.61	-11	-1.61	-0.27
Total Pre-Tax Income	-9.03	-15	-3.40	0.11	3.37	5.41	6.06	-1.61	0.25	-1.61	-0.23
Total Operating Income	-9.32	-15	-3.33	0.14	3.41	5.49	6.13	-1.89	0.32	-1.89	-0.91
Total Gross Profit	11	18	43	32	43	52	72	39	36	41	44
Total Revenue	14	21	50	37	48	59	80	52	47	52	55
Operating Revenue	10	12	50	37	48	59	80	52	47	52	55
Total Cost of Revenue	2.82	2.94	6.45	4.31	5.57	6.51	7.67	13	10	12	11
Operating Cost of Revenue	2.82	2.94	6.45	4.31	5.57	6.51	7.67	13	10	12	11
Total Operating Expenses	20	33	25	32	39	47	66	43	36	43	45
Selling, General & Admin Expense	16	22	18	25	31	36	51	30	26	30	30
Marketing Expense	2.84	4.42	4.47	4.82	6.91	7.80	11	11	8.69	11	13
Depreciation Expense	1.27	2.57	2.02	1.56	1.90	2.73	3.92	1.37	1.28	1.37	1.64
Impairment Charge	0.00	3.52	0.42	0.59	0.11	-0.05	0.03	0.07	-0.02	0.07	0.01
Total Other Income / (Expense), net	0.28	-0.00	-0.06	-0.03	-0.04	-0.08	-0.07	0.00	-0.06	0.28	0.68
Other Income / (Expense), net	0.28	-0.00	-0.06	-0.03	-0.04	-0.08	-0.07	0.00	-0.06	0.28	0.68
Income Tax Expense	-0.24	0.16	0.04	-0.04	0.05	-7.75	-1.51	0.01	11	0.01	0.04
Net Income / (Loss) Discontinued Operations	-	-	-	-	-	-	-	-4.18	1.02	-4.18	3.18
Basic Earnings per Share	($0.88)	($1.20)	($0.26)	$0.01	$0.24	$0.94	$0.53	($0.39)	($0.66)	($0.39)	$0.19
Weighted Average Basic Shares Outstanding	10.04M	12.70M	13.25M	13.67M	13.82M	14.00M	14.32M	0.00	14.69M	14.92M	15.13M
Diluted Earnings per Share	($0.88)	($1.20)	($0.26)	$0.01	$0.23	$0.90	$0.51	($0.38)	($0.65)	($0.38)	$0.19
Weighted Average Diluted Shares Outstanding	10.04M	12.70M	13.25M	14.03M	14.47M	14.58M	14.94M	0.00	14.94M	15.15M	15.19M
Weighted Average Basic & Diluted Shares Outstanding	10.04M	12.70M	13.25M	13.74M	13.88M	14.14M	14.42M	14.57M	14.78M	15.17M	14.11M

This table shows Joint's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026	Q2 2026
Period end date	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025	12/31/2025	3/31/2026	6/30/2026
Net Income / (Loss) Attributable to Common Shareholders	-11	0.95	-3.60	-3.17	-2.72	0.97	0.09	0.86	0.99	1.30	0.65
Consolidated Net Income / (Loss)	-11	0.95	-3.60	-3.17	-2.72	0.97	0.09	0.86	0.99	1.30	0.65
Net Income / (Loss) Continuing Operations	-12	-0.40	-1.71	-0.41	4.28	-0.51	-0.99	0.29	0.94	1.10	-0.25
Total Pre-Tax Income	-1.53	-0.39	-1.70	-0.41	3.92	-0.49	-0.98	0.30	0.94	1.11	-0.24
Total Operating Income	2.24	-0.43	-1.78	-0.49	3.84	-0.68	-1.14	0.16	0.74	0.87	-0.37
Total Gross Profit	-43	9.48	9.80	9.84	-41	10	10	11	12	12	13
Total Revenue	-40	12	13	13	-38	13	13	13	15	15	15
Operating Revenue	-40	12	13	13	-38	13	13	13	15	15	15
Total Cost of Revenue	2.81	2.70	2.81	2.81	3.15	2.97	2.77	2.66	2.82	2.72	2.48
Operating Cost of Revenue	2.81	2.70	2.81	2.81	3.15	2.97	2.77	2.66	2.82	2.72	2.48
Total Operating Expenses	-45	9.91	12	10	-45	11	12	11	12	11	13
Selling, General & Admin Expense	-34	7.34	7.79	7.48	-34	6.91	7.75	7.30	7.68	7.08	7.56
Marketing Expense	-4.48	2.24	3.44	2.50	-3.13	3.51	3.48	2.82	3.49	3.72	4.89
Depreciation Expense	-5.62	0.33	0.34	0.35	-2.80	0.36	0.40	0.45	0.43	0.40	0.42
Impairment Charge	-1.07	0.00	0.00	0.00	-5.59	0.00	0.00	0.00	0.00	0.03	0.21
Total Other Income / (Expense), net	-3.77	0.04	0.08	0.08	0.08	0.19	0.16	0.14	0.20	0.24	0.13
Other Income / (Expense), net	-3.77	0.04	0.08	0.08	0.08	0.19	0.16	0.14	0.20	0.24	0.13
Income Tax Expense	11	0.01	0.01	0.01	-0.36	0.01	0.01	0.01	0.00	0.01	0.01
Net Income / (Loss) Discontinued Operations	-	1.35	-1.89	-2.75	-	1.47	1.08	0.56	0.05	0.20	0.90
Basic Earnings per Share	($0.75)	$0.06	($0.24)	($0.21)	($0.18)	$0.06	$0.01	$0.06	$0.06	$0.09	$0.05
Weighted Average Basic Shares Outstanding	14.69M	14.80M	14.95M	14.96M	14.92M	15.19M	15.33M	15.34M	15.13M	14.18M	14.24M
Diluted Earnings per Share	($0.74)	$0.06	($0.24)	($0.21)	($0.17)	$0.06	$0.01	$0.06	$0.06	$0.09	$0.05
Weighted Average Diluted Shares Outstanding	14.94M	15.01M	15.21M	15.19M	15.15M	15.26M	15.40M	15.40M	15.19M	14.19M	14.25M
Weighted Average Basic & Diluted Shares Outstanding	14.78M	14.97M	15.00M	14.98M	15.17M	15.30M	15.34M	14.87M	14.11M	14.26M	14.14M

This table details how cash moves in and out of Joint's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Net Change in Cash & Equivalents	-4.00	-14	0.98	4.53	-0.21	12	-0.91	-9.36	8.66	6.78	-1.69
Net Cash From Operating Activities	-6.80	-11	-0.07	5.45	7.52	11	14	8.21	15	9.42	1.84
Net Cash From Continuing Operating Activities	-6.80	-11	-0.07	5.45	7.52	11	14	8.21	15	9.42	1.84
Net Income / (Loss) Continuing Operations	-8.80	-15	-3.43	0.15	3.32	13	7.57	0.63	-9.75	-5.80	2.91
Consolidated Net Income / (Loss)	-8.80	-15	-3.43	0.15	3.32	13	7.57	0.63	-9.75	-5.80	2.91
Depreciation Expense	1.27	2.57	2.02	1.56	1.90	2.73	3.92	6.65	8.58	4.72	1.71
Non-Cash Adjustments To Reconcile Net Income	-0.50	4.25	0.88	0.98	0.70	0.83	0.48	1.62	3.55	9.44	6.40
Changes in Operating Assets and Liabilities, net	1.24	-2.49	0.46	2.77	1.60	-5.55	1.88	-0.68	12	1.05	-9.18
Net Cash From Investing Activities	-10	-2.70	-0.37	-1.24	-7.14	-4.60	-13	-18	-6.19	-0.63	6.27
Net Cash From Continuing Investing Activities	-10	-2.70	-0.37	-1.24	-7.14	-4.60	-13	-18	-6.19	-0.63	6.27
Purchase of Property, Plant & Equipment	-4.07	-1.57	-0.45	-1.11	-3.48	-3.16	-6.99	-5.90	-5.00	-1.19	-1.50
Divestitures	-	-	-	-	-	-	0.00	0.11	0.00	0.55	7.78
Net Cash From Financing Activities	13	-0.24	1.42	0.33	-0.60	5.60	-2.00	0.33	0.17	-2.00	-9.81
Net Cash From Continuing Financing Activities	13	-0.24	1.42	0.33	-0.60	5.60	-2.00	0.33	0.17	-2.00	-9.81
Repayment of Debt	-0.22	-0.44	-0.23	0.00	-1.10	0.00	-2.73	-	0.00	-2.00	0.00
Repurchase of Common Equity	0.00	-0.08	-0.00	-0.00	-0.02	-0.03	-0.71	-0.01	-0.00	0.00	-11
Other Financing Activities, net	-1.35	0.07	0.36	0.33	0.52	3.68	1.44	0.33	0.18	-0.00	1.51
Cash Interest Paid	-	-	-	-	-	-	-	-	0.17	0.07	0.05
Cash Income Taxes Paid	-	-	-	-	-	-	-	-	0.57	0.61	0.63

This table details how cash moves in and out of Joint's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026	Q2 2026
Period end date	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025	12/31/2025	3/31/2026	6/30/2026
Net Change in Cash & Equivalents	2.07	0.45	-1.02	3.35	4.00	-3.10	8.10	-0.29	-6.41	-2.88	2.40
Net Cash From Operating Activities	3.38	2.81	-0.97	3.45	4.13	-3.70	0.87	1.77	2.90	-1.48	2.19
Net Cash From Continuing Operating Activities	3.38	2.81	-0.97	3.45	4.13	-3.70	0.87	1.77	2.90	-1.47	2.18
Net Income / (Loss) Continuing Operations	-11	0.95	-3.60	-3.17	-2.72	0.97	0.26	0.86	0.99	1.30	0.65
Consolidated Net Income / (Loss)	-11	0.95	-3.60	-3.17	-2.72	0.97	0.26	0.86	0.99	1.30	0.65
Depreciation Expense	1.69	1.40	1.52	1.24	0.56	0.39	0.42	0.46	0.44	0.40	0.42
Non-Cash Adjustments To Reconcile Net Income	1.40	0.82	1.79	4.48	5.06	1.26	1.78	1.20	2.00	0.37	1.25
Changes in Operating Assets and Liabilities, net	11	-0.36	-0.69	0.90	1.23	-6.31	-1.59	-0.75	-0.54	-3.54	-0.15
Net Cash From Investing Activities	-1.30	-0.34	-0.09	-0.09	-0.10	-0.29	7.23	-0.32	-0.35	-0.23	0.90
Net Cash From Continuing Investing Activities	-1.30	-0.34	-0.09	-0.09	-0.10	-0.29	7.23	-0.32	-0.35	-0.23	0.90
Purchase of Property, Plant & Equipment	-1.17	-0.40	-0.26	-0.24	-0.28	-0.33	-0.51	-0.32	-0.35	-0.23	-0.26
Divestitures	-	0.05	0.17	0.15	0.18	0.04	7.74	-	-	0.00	1.16
Net Cash From Financing Activities	-0.01	-2.01	0.04	-0.01	-0.02	0.89	-	-1.74	-8.96	-1.16	-0.70
Net Cash From Continuing Financing Activities	-0.01	-2.01	0.04	-0.01	-0.02	0.89	-	-1.74	-8.96	-1.16	-0.70
Repurchase of Common Equity	-0.00	-0.01	-0.00	0.01	-	0.00	-	-2.28	-9.02	-1.15	-0.68
Other Financing Activities, net	-0.01	-0.01	0.05	-0.02	-0.02	0.89	-	0.54	0.07	-0.02	-0.02
Cash Interest Paid	0.01	0.02	0.01	0.03	0.01	0.01	0.01	0.01	0.01	0.01	0.01
Cash Income Taxes Paid	0.10	0.00	0.41	0.10	0.10	-0.06	0.44	0.16	0.08	0.00	0.14

This table presents Joint's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Total Assets	33	17	18	23	44	66	87	93	87	83	61
Total Current Assets	19	5.70	6.67	11	13	25	27	18	44	75	52
Cash & Equivalents	17	3.01	4.22	8.72	8.46	21	20	9.75	18	25	24
Restricted Cash	0.39	0.33	0.10	0.14	0.19	0.27	0.39	0.81	1.06	0.95	0.70
Accounts Receivable	0.74	1.02	1.14	0.81	2.65	2.06	3.70	3.91	2.58	2.59	2.85
Prepaid Expenses	0.37	0.50	0.54	0.88	1.12	1.57	2.28	2.10	1.84	1.79	1.74
Other Current Assets	0.61	0.75	0.50	0.61	0.77	0.90	0.99	1.05	1.05	1.06	0.95
Other Current Nonoperating Assets	-	-	-	-	-	-	-	-	20	43	22
Plant, Property, & Equipment, net	7.14	4.72	3.80	3.66	6.58	0.00	0.00	0.00	3.81	3.21	3.16
Total Noncurrent Assets	7.20	6.63	7.96	8.47	24	41	60	76	39	5.37	5.72
Other Noncurrent Operating Assets	2.17	1.54	2.94	3.48	16	25	39	45	5.92	5.37	5.72
Total Liabilities & Shareholders' Equity	33	17	18	23	44	66	87	93	87	83	61
Total Liabilities	13	10	17	23	38	45	57	61	62	62	46
Total Current Liabilities	7.49	5.86	5.38	10	14	18	21	23	34	49	33
Accounts Payable	2.00	1.05	1.07	1.25	1.53	1.56	1.71	2.97	1.25	1.75	1.59
Accrued Expenses	0.38	0.30	0.09	0.27	0.22	0.77	1.81	1.07	1.16	1.51	1.50
Current Deferred Revenue	2.91	3.29	3.01	5.04	5.94	6.68	7.66	9.94	2.52	2.55	2.52
Current Employee Benefit Liabilities	1.49	0.75	0.87	2.04	2.84	2.78	3.91	2.03	0.86	3.55	4.06
Other Current Liabilities	0.26	0.13	0.24	0.58	3.04	6.67	6.36	7.21	2.32	2.32	1.78
Other Current Nonoperating Liabilities	-	-	-	-	-	-	-	0.00	25	37	21
Total Noncurrent Liabilities	5.20	4.27	12	12	24	26	35	38	29	13	13
Noncurrent Deferred Revenue	4.83	3.63	10	12	-	14	13	14	14	12	11
Other Noncurrent Operating Liabilities	0.24	0.51	0.41	0.39	24	0.16	20	21	1.52	0.98	2.17
Commitments & Contingencies	0.00	0.00	0.00	0.00	-	-	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	21	6.93	1.15	0.73	5.72	21	30	33	25	21	15
Total Preferred & Common Equity	21	6.93	1.15	0.73	5.72	21	30	33	25	21	15
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	21	6.93	1.15	0.73	5.72	21	30	33	25	21	15
Common Stock	35	36	37	38	39	41	44	46	48	49	52
Retained Earnings	-14	-29	-36	-37	-34	-20	-13	-12	-22	-28	-25
Treasury Stock	-0.79	-0.50	-0.09	-0.09	-0.11	-0.14	-0.85	-0.86	-0.86	-0.87	-12
Noncontrolling Interest	-	-	-	0.00	0.00	0.00	0.03	0.03	0.03	0.03	0.03

This table presents Joint's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q3 2023	Q1 2024	Q2 2024	Q3 2024	Q1 2025	Q2 2025	Q3 2025	Q1 2026	Q2 2026
Period end date	9/30/2023	3/31/2024	6/30/2024	9/30/2024	3/31/2025	6/30/2025	9/30/2025	3/31/2026	6/30/2026
Total Assets	99	86	82	80	80	73	69	58	52
Total Current Assets	28	45	43	55	71	64	61	50	44
Cash & Equivalents	16	19	17	21	22	30	30	21	22
Restricted Cash	1.09	0.92	1.19	1.26	0.98	1.19	1.01	0.74	0.85
Accounts Receivable	3.65	3.27	3.58	4.30	2.97	2.79	2.90	2.34	2.41
Prepaid Expenses	2.60	2.93	3.44	2.49	3.80	2.71	2.06	3.14	2.74
Other Current Assets	5.03	19	18	26	1.05	0.97	1.11	0.90	0.90
Other Current Nonoperating Assets	-	-	-	-	40	26	24	22	15
Plant, Property, & Equipment, net	0.00	0.00	0.00	0.00	3.06	3.18	3.04	3.04	2.82
Total Noncurrent Assets	70	41	39	24	6.30	6.26	5.85	5.29	5.00
Other Noncurrent Operating Assets	41	28	26	19	6.30	6.26	5.85	5.29	5.00
Total Liabilities & Shareholders' Equity	99	86	82	80	80	73	69	58	52
Total Liabilities	63	59	59	59	57	50	47	42	36
Total Current Liabilities	28	33	34	38	43	36	33	30	24
Accounts Payable	1.88	1.28	1.64	1.90	1.02	1.58	1.20	0.96	1.10
Accrued Expenses	2.49	1.96	3.16	4.09	2.01	1.28	0.76	1.61	1.86
Current Deferred Revenue	9.05	7.13	6.94	5.72	2.53	2.58	2.52	2.49	2.70
Current Employee Benefit Liabilities	3.88	4.51	4.27	6.11	2.19	2.39	3.42	2.10	2.14
Other Current Liabilities	7.41	5.63	5.86	5.34	2.21	2.29	2.26	1.81	1.83
Other Current Nonoperating Liabilities	2.97	13	12	15	33	25	23	21	14
Total Noncurrent Liabilities	36	26	25	21	15	14	14	12	12
Noncurrent Deferred Revenue	14	13	13	13	12	12	11	10	9.86
Other Noncurrent Operating Liabilities	20	13	12	8.14	2.61	2.48	2.33	2.05	1.70
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	35	26	23	20	23	23	23	15	16
Total Preferred & Common Equity	35	26	23	20	23	23	23	15	16
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	35	26	23	20	23	23	23	15	16
Common Stock	47	48	49	49	50	51	52	52	53
Retained Earnings	-11	-21	-25	-28	-27	-27	-26	-23	-23
Treasury Stock	-0.86	-0.87	-0.87	-0.87	-0.88	-0.88	-3.17	-13	-14
Noncontrolling Interest	0.03	0.03	0.03	0.03	0.03	0.03	0.03	0.03	0.03

This table displays calculated financial ratios and metrics derived from Joint's official financial filings.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
DEI Shares Outstanding	9,906,491.00	12,720,399.00	13,518,146.00	13,734,193.00	13,863,085.00	14,041,146.00	14,413,339.00	14,529,679.00	14,754,287.00	-	14,866,192.00
DEI Adjusted Shares Outstanding	9,906,491.00	12,720,399.00	13,518,146.00	13,734,193.00	13,863,085.00	14,041,146.00	14,413,339.00	14,529,679.00	14,754,287.00	-	14,866,192.00
DEI Earnings Per Adjusted Shares Outstanding	-0.89	-1.19	1.35	0.01	0.24	0.94	0.52	-0.52	-0.66	-	0.20
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	94.41%	48.34%	142.83%	-26.44%	32.16%	21.12%	36.34%	-34.80%	-9.94%	10.47%	5.24%
EBITDA Growth	-424.38%	-60.26%	88.92%	220.74%	216.58%	54.55%	22.47%	-52.32%	85.73%	-63.25%	-52.33%
EBIT Growth	-434.26%	-66.16%	77.37%	103.21%	2,994.87%	60.50%	11.89%	-131.19%	113.45%	-680.60%	85.73%
NOPAT Growth	-472.72%	-61.09%	77.80%	108.23%	1,653.50%	297.01%	-42.72%	-117.28%	-920.58%	90.90%	51.65%
Net Income Growth	-190.22%	-72.48%	77.38%	104.27%	2,165.71%	296.16%	-42.55%	-176.63%	-68.23%	12.53%	150.15%
EPS Growth	-57.14%	-36.36%	78.33%	103.85%	2,200.00%	291.30%	-43.33%	-174.51%	-71.05%	13.85%	150.00%
Operating Cash Flow Growth	-1,453.68%	-59.60%	99.32%	7,454.91%	37.96%	48.67%	23.79%	-40.70%	78.79%	-35.85%	-80.47%
Free Cash Flow Firm Growth	-2,856.74%	35.40%	135.29%	41.29%	-114.37%	-237.54%	424.29%	-259.60%	243.99%	-89.75%	-193.55%
Invested Capital Growth	175.70%	-4.17%	-152.82%	-240.04%	58.43%	542.92%	-3.52%	93.05%	-133.30%	-39.11%	9.02%
Revenue Q/Q Growth	14.08%	10.91%	67.84%	-30.33%	8.77%	5.70%	5.56%	-44.99%	-59.06%	-57.04%	0.83%
EBITDA Q/Q Growth	-32.26%	-17.95%	79.29%	67.39%	24.42%	22.70%	-23.18%	10.82%	-27.20%	924.50%	-3.95%
EBIT Q/Q Growth	-33.60%	-16.31%	61.70%	116.66%	32.04%	35.76%	-24.69%	-2,889.79%	-92.00%	73.37%	18.24%
NOPAT Q/Q Growth	-37.79%	-17.33%	62.26%	144.17%	33.58%	242.64%	-56.86%	-225.90%	-4,432.51%	69.43%	-7.96%
Net Income Q/Q Growth	-10.19%	-18.60%	61.78%	129.15%	34.64%	244.12%	-56.94%	-1,275.48%	-575.10%	49.40%	50.34%
EPS Q/Q Growth	13.73%	-12.15%	62.86%	133.33%	35.29%	233.33%	-57.14%	-1,366.67%	-564.29%	50.44%	35.71%
Operating Cash Flow Q/Q Growth	-56.90%	17.39%	96.46%	60.00%	-9.04%	15.00%	-17.24%	85.53%	-10.89%	8.62%	-40.14%
Free Cash Flow Firm Q/Q Growth	0.00%	35.00%	896.71%	-13.17%	92.16%	-113.66%	183.66%	-229.29%	179.84%	-65.38%	-107.51%
Invested Capital Q/Q Growth	129.25%	-55.18%	-168.72%	-109.05%	-133.95%	322.99%	37.52%	19,771.98%	-134.65%	-181.95%	-14.36%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	79.62%	85.68%	87.06%	88.24%	88.51%	88.91%	90.42%	75.14%	77.69%	77.81%	79.55%
EBITDA Margin	-56.12%	-60.63%	-2.77%	4.54%	10.88%	13.88%	12.47%	9.12%	18.81%	6.26%	2.70%
Operating Margin	-67.34%	-73.13%	-6.69%	0.39%	7.05%	9.36%	7.66%	-3.62%	0.68%	-3.38%	-1.66%
EBIT Margin	-65.29%	-73.13%	-6.82%	0.30%	6.96%	9.22%	7.57%	-3.62%	0.54%	-2.84%	-0.42%
Profit (Net Income) Margin	-63.59%	-73.93%	-6.89%	0.40%	6.86%	22.44%	9.46%	-11.11%	-20.76%	-16.44%	5.30%
Tax Burden Percent	97.39%	101.10%	101.06%	134.62%	98.56%	243.27%	124.92%	360.34%	-3,839.36%	578.38%	-1,266.76%
Interest Burden Percent	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	85.16%	100.00%	100.00%	100.00%
Effective Tax Rate	0.00%	0.00%	0.00%	-34.62%	1.44%	-143.27%	-24.92%	0.00%	4,339.82%	0.00%	0.00%
Return on Invested Capital (ROIC)	0.00%	-262.78%	-252.70%	0.00%	0.00%	266.74%	60.20%	-7.23%	-167.90%	0.00%	0.00%
ROIC Less NNEP Spread (ROIC-NNEP)	0.00%	-215.17%	-217.40%	0.00%	0.00%	269.03%	60.87%	26.78%	-186.03%	0.00%	0.00%
Return on Net Nonoperating Assets (RNNOA)	0.00%	152.84%	167.72%	0.00%	0.00%	-168.64%	-30.78%	-11.20%	133.89%	0.00%	0.00%
Return on Equity (ROE)	-48.46%	-109.94%	-84.97%	15.60%	103.09%	98.09%	29.42%	-18.43%	-34.00%	-39.94%	16.26%
Cash Return on Invested Capital (CROIC)	-391.83%	-258.52%	0.00%	0.00%	0.00%	-19.32%	63.78%	-70.73%	0.00%	0.00%	0.00%
Operating Return on Assets (OROA)	-29.22%	-59.54%	-19.14%	0.52%	10.05%	9.88%	7.92%	-2.09%	0.28%	-1.76%	-0.32%
Return on Assets (ROA)	-28.45%	-60.19%	-19.34%	0.70%	9.90%	24.03%	9.89%	-6.42%	-10.79%	-10.18%	4.03%
Return on Common Equity (ROCE)	-48.46%	-109.94%	-84.97%	15.60%	103.09%	98.09%	29.40%	-18.42%	-33.97%	-39.89%	16.24%
Return on Equity Simple (ROE_SIMPLE)	-42.54%	-219.10%	-297.58%	20.16%	58.10%	62.33%	24.98%	0.00%	0.00%	-47.60%	0.00%
Net Operating Profit after Tax (NOPAT)	-6.52	-11	-2.33	0.19	3.37	13	7.65	-1.32	-13	-1.23	-0.64
NOPAT Margin	-47.14%	-51.19%	-4.68%	0.52%	6.95%	22.77%	9.56%	-2.54%	-28.73%	-2.37%	-1.16%
Net Nonoperating Expense Percent (NNEP)	-12.10%	-47.61%	-35.30%	-0.82%	-0.51%	-2.30%	-0.67%	-34.01%	18.13%	-23.59%	12.45%
Return On Investment Capital (ROIC_SIMPLE)	-	-	-	-	-	-	-	-3.82%	-50.41%	-6.85%	-4.24%
Cost of Revenue to Revenue	20.38%	14.32%	12.94%	11.76%	11.49%	11.09%	9.58%	24.86%	22.31%	22.19%	20.45%
SG&A Expenses to Revenue	117.23%	107.61%	36.35%	68.84%	63.04%	61.68%	63.55%	57.75%	55.84%	57.49%	53.98%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	146.96%	158.80%	50.22%	87.85%	81.46%	79.55%	82.76%	81.54%	77.01%	81.19%	81.22%
Earnings before Interest and Taxes (EBIT)	-9.03	-15	-3.40	0.11	3.37	5.41	6.06	-1.89	0.25	-1.47	-0.23
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	-7.76	-12	-1.38	1.67	5.27	8.15	9.98	4.76	8.84	3.25	1.48
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	2.86	4.87	58.13	157.07	39.11	17.45	31.26	6.24	5.73	8.89	8.61
Price to Tangible Book Value (P/TBV)	3.77	18.36	0.00	0.00	0.00	27.04	46.22	15.46	5.73	8.89	8.61
Price to Revenue (P/Rev)	4.27	1.64	1.35	3.12	4.62	6.28	11.83	3.89	3.02	3.07	2.36
Price to Earnings (P/E)	0.00	0.00	3.67	778.95	67.32	28.00	125.16	0.00	0.00	0.00	44.59
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	0.00%	0.00%	27.24%	0.13%	1.49%	3.57%	0.80%	0.00%	0.00%	0.00%	2.24%
Enterprise Value to Invested Capital (EV/IC)	10.42	7.85	0.00	0.00	0.00	27.86	74.41	8.08	0.00	0.00	0.00
Enterprise Value to Revenue (EV/Rev)	3.08	1.50	1.28	2.91	4.44	6.14	11.61	3.73	2.65	2.57	1.92
Enterprise Value to EBITDA (EV/EBITDA)	0.00	0.00	0.00	63.96	40.80	44.25	93.11	40.92	14.10	41.05	70.98
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	0.00	977.48	63.78	66.61	153.40	0.00	490.54	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	0.00	554.99	63.92	26.98	121.40	0.00	0.00	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	0.00	0.00	0.00	19.54	28.60	32.24	67.11	23.71	8.49	14.16	57.31
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	17.50	20.67	0.00	0.00	114.59	0.00	6.69	69.78	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.03	0.05	0.95	1.51	0.00	0.60	0.07	0.06	0.08	0.00	0.00
Long-Term Debt to Equity	0.01	0.00	0.87	0.00	0.00	0.60	0.07	0.06	0.08	0.00	0.00
Financial Leverage	-1.04	-0.71	-0.77	-5.83	-2.54	-0.63	-0.51	-0.42	-0.72	-1.45	-1.59
Leverage Ratio	1.70	1.83	4.39	22.26	10.41	4.08	2.97	2.87	3.15	3.92	4.03
Compound Leverage Factor	1.70	1.83	4.39	22.26	10.41	4.08	2.97	2.44	3.15	3.92	4.03
Debt to Total Capital	2.74%	4.57%	48.81%	60.19%	0.00%	37.42%	6.44%	5.96%	7.47%	0.00%	0.00%
Short-Term Debt to Total Capital	2.13%	4.57%	4.44%	60.19%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Long-Term Debt to Total Capital	0.61%	0.00%	44.38%	0.00%	0.00%	37.42%	6.44%	5.96%	7.47%	0.00%	0.00%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.01%	0.00%	0.00%	0.08%	0.07%	0.09%	0.14%	0.17%
Common Equity to Total Capital	97.26%	95.43%	51.19%	39.81%	100.00%	62.58%	93.48%	93.97%	92.44%	99.86%	99.83%
Debt to EBITDA	-0.07	-0.03	-0.80	0.66	0.00	1.55	0.21	0.43	0.23	0.00	0.00
Net Debt to EBITDA	2.14	0.24	2.33	-4.66	0.00	-1.00	-1.79	-1.78	-1.95	0.00	0.00
Long-Term Debt to EBITDA	-0.02	0.00	-0.73	0.00	0.00	1.55	0.21	0.43	0.23	0.00	0.00
Debt to NOPAT	-0.09	-0.03	-0.47	5.73	0.00	0.95	0.27	-1.56	-0.15	0.00	0.00
Net Debt to NOPAT	2.54	0.29	1.38	-40.41	0.00	-0.61	-2.33	6.42	1.28	0.00	0.00
Long-Term Debt to NOPAT	-0.02	0.00	-0.43	0.00	0.00	0.95	0.27	-1.56	-0.15	0.00	0.00
Altman Z-Score	2.15	-2.10	1.77	2.42	3.81	5.80	11.03	2.24	1.71	1.93	2.39
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.01%	0.00%	0.00%	0.05%	0.08%	0.09%	0.12%	0.14%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	2.54	0.97	1.24	1.10	0.98	1.37	1.25	0.76	1.32	1.46	1.59
Quick Ratio	2.35	0.69	1.03	0.94	0.83	1.23	1.08	0.59	0.62	0.56	0.81
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-16	-10	3.65	5.15	-0.74	-2.50	8.11	-13	19	1.91	-1.64
Operating Cash Flow to CapEx	-167.63%	-691.91%	-16.50%	490.70%	215.93%	354.32%	198.07%	139.17%	293.61%	794.09%	122.26%
Free Cash Flow to Firm to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.45	0.81	2.81	1.75	1.44	1.07	1.05	0.58	0.52	0.62	0.76
Accounts Receivable Turnover	19.11	23.26	46.14	37.70	28.08	24.93	27.76	13.71	14.47	20.09	20.20
Inventory Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fixed Asset Turnover	3.34	3.46	11.69	9.83	9.46	0.00	0.00	0.00	0.00	14.89	17.25
Accounts Payable Turnover	1.78	1.93	6.07	3.71	4.01	4.22	4.69	5.55	4.97	7.67	6.72
Days Sales Outstanding (DSO)	19.10	15.69	7.91	9.68	13.00	14.64	13.15	26.63	25.22	18.17	18.07
Days Inventory Outstanding (DIO)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Days Payable Outstanding (DPO)	205.54	189.47	60.10	98.31	91.12	86.59	77.79	65.74	73.49	47.62	54.29
Cash Conversion Cycle (CCC)	-186.44	-173.78	-52.19	-88.63	-78.12	-71.95	-64.64	-39.11	-48.27	-29.45	-36.22
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	4.08	3.91	-2.07	-7.03	-2.92	13	12	24	-8.03	-11	-10
Invested Capital Turnover	-21.11	5.13	53.99	-8.06	-9.74	11.72	6.29	2.85	5.84	-5.41	-5.18
Increase / (Decrease) in Invested Capital	9.48	-0.17	-5.98	-4.96	4.11	16	-0.46	12	-32	-3.14	1.00
Enterprise Value (EV)	43	31	64	107	215	361	929	195	125	133	105
Market Capitalization	59	34	67	114	224	369	947	203	142	159	130
Book Value per Share	$2.09	$0.54	$0.09	$0.05	$0.41	$1.50	$2.10	$2.24	$1.68	$1.20	$1.01
Tangible Book Value per Share	$1.58	$0.14	($0.26)	($0.30)	($0.12)	$0.97	$1.42	$0.90	$1.68	$1.20	$1.01
Total Capital	21	7.26	2.25	1.83	5.72	34	32	35	27	18	15
Total Debt	0.58	0.33	1.10	1.10	0.00	13	2.09	2.06	2.00	0.00	0.00
Total Long-Term Debt	0.13	0.00	1.00	0.00	0.00	13	2.09	2.06	2.00	0.00	0.00
Net Debt	-17	-3.01	-3.22	-7.75	-8.64	-8.19	-18	-8.49	-17	-26	-24
Capital Expenditures (CapEx)	4.05	1.57	0.45	1.11	3.48	3.16	6.99	5.90	5.00	1.19	1.50
Debt-free, Cash-free Net Working Capital (DFCFNWC)	-5.19	-3.18	-2.93	-6.72	-8.90	-14	-14	-16	-8.45	-3.16	-5.03
Debt-free Net Working Capital (DFNWC)	12	0.16	1.39	2.13	-0.26	6.89	5.45	-5.60	11	23	19
Net Working Capital (NWC)	12	-0.17	1.29	1.03	-0.26	6.89	5.45	-5.60	11	23	19
Net Nonoperating Expense (NNE)	2.28	4.67	1.10	0.05	0.04	0.19	0.09	4.47	-3.74	7.30	-3.55
Net Nonoperating Obligations (NNO)	-17	-3.01	-3.22	-7.75	-8.64	-8.19	-18	-8.49	-33	-29	-25
Total Depreciation and Amortization (D&A)	1.27	2.57	2.02	1.56	1.90	2.73	3.92	6.65	8.58	4.72	1.71
Debt-free, Cash-free Net Working Capital to Revenue	-37.50%	-15.49%	-5.88%	-18.34%	-18.38%	-23.74%	-18.07%	-30.97%	-17.99%	-6.08%	-9.16%
Debt-free Net Working Capital to Revenue	86.66%	0.80%	2.79%	5.81%	-0.54%	11.74%	6.81%	-10.74%	22.91%	44.01%	35.11%
Net Working Capital to Revenue	83.39%	-0.81%	2.59%	2.81%	-0.54%	11.74%	6.81%	-10.74%	22.91%	44.01%	35.11%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	($0.88)	($1.20)	($0.25)	$0.02	$0.24	$0.94	$0.46	$0.08	($0.66)	($0.57)	$0.19
Adjusted Weighted Average Basic Shares Outstanding	12.58M	13.05M	13.59M	13.67M	13.82M	14.00M	14.32M	14.49M	14.69M	14.92M	15.13M
Adjusted Diluted Earnings per Share	($0.88)	($1.20)	($0.25)	$0.02	$0.23	$0.90	$0.44	$0.08	($0.65)	($0.56)	$0.19
Adjusted Weighted Average Diluted Shares Outstanding	12.58M	13.05M	13.59M	14.03M	14.47M	14.58M	14.94M	14.87M	14.94M	15.15M	15.19M
Adjusted Basic & Diluted Earnings per Share	($0.88)	($1.20)	($0.25)	$0.00	$0.24	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	10.04M	12.70M	13.25M	13.74M	13.88M	14.14M	14.42M	14.57M	14.78M	15.17M	14.11M
Normalized Net Operating Profit after Tax (NOPAT)	-6.52	-8.04	-2.04	0.52	3.48	3.81	4.31	-1.28	0.21	-1.22	-0.63
Normalized NOPAT Margin	-47.14%	-39.18%	-4.09%	1.41%	7.18%	6.49%	5.38%	-2.45%	0.44%	-2.35%	-1.15%
Pre Tax Income Margin	-65.29%	-73.13%	-6.82%	0.30%	6.96%	9.22%	7.57%	-3.08%	0.54%	-2.84%	-0.42%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
EBIT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	0.00%	-0.56%	-0.08%	3.28%	0.61%	0.24%	9.36%	-0.10%	-0.04%	-0.11%	389.15%

This table displays calculated financial ratios and metrics derived from Joint's official financial filings.

Metric	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026	Q2 2026
Period end date	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025	12/31/2025	3/31/2026	6/30/2026
DEI Shares Outstanding	14,754,287.00	14,776,243.00	14,973,910.00	14,996,775.00	-	30,349,862.00	30,605,544.00	15,343,377.00	14,866,192.00	14,114,334.00	14,255,396.00
DEI Adjusted Shares Outstanding	14,754,287.00	14,776,243.00	14,973,910.00	14,996,775.00	-	30,349,862.00	30,605,544.00	15,343,377.00	14,866,192.00	14,114,334.00	14,255,396.00
DEI Earnings Per Adjusted Shares Outstanding	-0.75	0.06	-0.24	-0.21	-	0.03	0.00	0.06	0.07	0.09	0.05
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	-87.31%	-56.95%	-56.97%	-57.07%	4.54%	7.33%	5.24%	5.74%	3.08%	13.33%	14.41%
EBITDA Growth	-81.75%	-81.17%	-109.47%	-42.54%	2,697.10%	-110.29%	-219.26%	-8.01%	-4.23%	1,555.74%	132.63%
EBIT Growth	-28.30%	-112.32%	-253.14%	54.77%	356.43%	-26.20%	42.42%	173.53%	5.76%	326.12%	75.24%
NOPAT Growth	279.21%	37.73%	-375.05%	45.12%	166.67%	-59.06%	36.03%	145.04%	-10.62%	282.11%	67.61%
Net Income Growth	-95.07%	-59.29%	-1,022.16%	-341.89%	75.41%	2.20%	102.60%	127.01%	5,510.51%	34.24%	599.44%
EPS Growth	-100.00%	-62.50%	-1,100.00%	-320.00%	77.03%	0.00%	104.17%	128.57%	500.00%	50.00%	400.00%
Operating Cash Flow Growth	-34.66%	-53.35%	-166.29%	-9.30%	22.09%	-231.68%	189.23%	-48.58%	-29.85%	60.11%	152.37%
Free Cash Flow Firm Growth	369.72%	108.18%	121.42%	138.84%	-78.25%	1,111.70%	367.50%	145.99%	-106.71%	-99.82%	-106.48%
Invested Capital Growth	-133.30%	-11.27%	-27.99%	-41.18%	-39.11%	-137.76%	-151.71%	-164.83%	9.02%	11.16%	15.43%
Revenue Q/Q Growth	-236.07%	130.38%	3.49%	0.35%	-226.78%	-11.12%	1.47%	0.83%	13.35%	-2.29%	2.44%
EBITDA Q/Q Growth	-88.93%	533.51%	-117.27%	574.31%	340.17%	-107.22%	-435.79%	236.67%	81.15%	9.74%	-87.99%
EBIT Q/Q Growth	-69.05%	74.47%	-335.23%	75.93%	226.35%	-155.38%	-98.58%	130.74%	212.80%	18.42%	-121.75%
NOPAT Q/Q Growth	349.88%	-119.01%	-317.10%	72.30%	287.83%	-157.40%	-67.74%	119.50%	376.02%	16.94%	-129.84%
Net Income Q/Q Growth	-1,441.54%	108.58%	-479.78%	11.99%	14.21%	5,378.61%	-88.35%	815.79%	15.92%	31.08%	-49.73%
EPS Q/Q Growth	-1,380.00%	108.11%	-500.00%	12.50%	19.05%	500.00%	-80.00%	500.00%	0.00%	50.00%	-44.44%
Operating Cash Flow Q/Q Growth	-11.02%	-16.92%	-134.64%	454.21%	19.78%	-189.60%	123.47%	104.11%	63.42%	-150.95%	248.51%
Free Cash Flow Firm Q/Q Growth	242.38%	-93.57%	142.67%	74.81%	0.29%	572.48%	-6.58%	-8.02%	-101.16%	118.03%	-3,470.04%
Invested Capital Q/Q Growth	-134.65%	341.78%	-13.79%	-18.56%	-181.95%	34.01%	-17.12%	-2.11%	-14.36%	35.56%	-12.39%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	0.00%	77.80%	77.70%	77.76%	0.00%	77.27%	79.11%	80.11%	81.41%	81.63%	83.68%
EBITDA Margin	0.00%	8.32%	-1.39%	6.56%	0.00%	-0.80%	-4.21%	5.71%	9.12%	10.25%	1.20%
Operating Margin	0.00%	-3.50%	-14.11%	-3.89%	0.00%	-5.19%	-8.58%	1.20%	4.89%	5.90%	-2.43%
EBIT Margin	0.00%	-3.20%	-13.47%	-3.23%	0.00%	-3.77%	-7.37%	2.25%	6.20%	7.52%	-1.60%
Profit (Net Income) Margin	0.00%	7.77%	-28.52%	-25.01%	0.00%	7.40%	0.70%	6.39%	6.53%	8.77%	4.30%
Tax Burden Percent	722.30%	-242.61%	211.70%	773.89%	-69.27%	-196.46%	-9.54%	284.32%	105.36%	116.63%	-269.60%
Interest Burden Percent	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%
Effective Tax Rate	0.00%	0.00%	0.00%	0.00%	-9.12%	0.00%	0.00%	3.44%	0.37%	1.00%	0.00%
Return on Invested Capital (ROIC)	0.00%	-3.67%	-7.00%	0.00%	0.00%	-31.91%	-79.44%	26.39%	0.00%	0.00%	0.00%
ROIC Less NNEP Spread (ROIC-NNEP)	0.00%	-15.97%	18.10%	0.00%	0.00%	-39.72%	-84.08%	22.75%	0.00%	0.00%	0.00%
Return on Net Nonoperating Assets (RNNOA)	0.00%	5.26%	-5.78%	0.00%	0.00%	29.94%	69.46%	-20.23%	0.00%	0.00%	0.00%
Return on Equity (ROE)	0.00%	1.59%	-12.78%	-60.46%	-39.94%	-1.97%	-9.98%	6.17%	16.26%	16.90%	19.41%
Cash Return on Invested Capital (CROIC)	0.00%	13.80%	29.54%	50.12%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Return on Assets (OROA)	0.00%	-1.07%	-2.10%	0.00%	0.00%	-2.41%	-5.06%	1.64%	4.72%	6.17%	-1.50%
Return on Assets (ROA)	0.00%	2.59%	-4.45%	0.00%	0.00%	4.74%	0.48%	4.67%	4.98%	7.19%	4.04%
Return on Common Equity (ROCE)	0.00%	1.59%	-12.77%	-60.40%	-39.89%	-1.97%	-9.97%	6.16%	16.24%	16.88%	19.39%
Return on Equity Simple (ROE_SIMPLE)	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Net Operating Profit after Tax (NOPAT)	1.57	-0.30	-1.25	-0.34	4.19	-0.47	-0.80	0.16	0.74	0.86	-0.26
NOPAT Margin	0.00%	-2.45%	-9.88%	-2.73%	0.00%	-3.63%	-6.00%	1.16%	4.88%	5.84%	-1.70%
Net Nonoperating Expense Percent (NNEP)	-61.10%	12.30%	-25.11%	-29.72%	-22.30%	7.81%	4.64%	3.64%	0.88%	1.66%	3.31%
Return On Investment Capital (ROIC_SIMPLE)	5.87%	-1.14%	-5.36%	-1.68%	23.34%	-2.08%	-3.43%	0.68%	4.90%	5.58%	-1.63%
Cost of Revenue to Revenue	0.00%	22.20%	22.30%	22.24%	0.00%	22.73%	20.89%	19.89%	18.59%	18.37%	16.32%
SG&A Expenses to Revenue	0.00%	60.23%	61.80%	59.10%	0.00%	52.88%	58.37%	54.52%	50.61%	47.81%	49.77%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	0.00%	81.31%	91.81%	81.65%	0.00%	82.46%	87.68%	78.91%	76.52%	75.73%	86.11%
Earnings before Interest and Taxes (EBIT)	-1.53	-0.39	-1.70	-0.41	3.92	-0.49	-0.98	0.30	0.94	1.11	-0.24
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	0.16	1.01	-0.18	0.83	4.48	-0.10	-0.56	0.76	1.38	1.52	0.18
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	5.73	7.37	9.08	8.39	8.89	8.31	7.60	6.45	8.61	8.07	7.90
Price to Tangible Book Value (P/TBV)	5.73	13.42	18.53	10.58	8.89	8.31	7.60	6.45	8.61	8.07	7.90
Price to Revenue (P/Rev)	3.02	6.25	14.86	0.00	3.07	3.57	3.30	2.69	2.36	2.21	2.14
Price to Earnings (P/E)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	75.69	44.59	38.57	32.95
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	1.32%	2.24%	2.59%	3.03%
Enterprise Value to Invested Capital (EV/IC)	0.00	8.93	11.47	10.98	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Revenue (EV/Rev)	2.65	5.62	13.55	0.00	2.57	3.14	2.72	2.12	1.92	1.83	1.75
Enterprise Value to EBITDA (EV/EBITDA)	14.10	38.81	78.55	81.81	41.05	83.52	83.42	74.87	70.98	33.32	26.55
Enterprise Value to EBIT (EV/EBIT)	490.54	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	75.17	48.36
Enterprise Value to NOPAT (EV/NOPAT)	0.00	454.59	0.00	0.00	0.00	0.00	0.00	0.00	0.00	166.43	73.75
Enterprise Value to Operating Cash Flow (EV/OCF)	8.49	15.12	21.28	17.26	14.16	57.39	30.68	37.67	57.31	25.48	18.97
Enterprise Value to Free Cash Flow (EV/FCFF)	6.69	60.90	32.52	16.23	69.78	6.61	5.96	5.29	0.00	0.00	2,008.19
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.08	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Long-Term Debt to Equity	0.08	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Financial Leverage	-0.72	-0.33	-0.32	-0.34	-1.45	-0.75	-0.83	-0.89	-1.59	-1.36	-1.41
Leverage Ratio	3.15	3.01	3.10	3.20	3.92	3.38	3.35	3.45	4.03	3.60	3.19
Compound Leverage Factor	3.15	3.01	3.10	3.20	3.92	3.38	3.35	3.45	4.03	3.60	3.19
Debt to Total Capital	7.47%	0.12%	0.11%	0.09%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Short-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Long-Term Debt to Total Capital	7.47%	0.12%	0.11%	0.09%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.09%	0.10%	0.11%	0.12%	0.14%	0.11%	0.11%	0.11%	0.17%	0.16%	0.16%
Common Equity to Total Capital	92.44%	99.78%	99.79%	99.79%	99.86%	99.89%	99.89%	99.89%	99.83%	99.84%	99.84%
Debt to EBITDA	0.23	0.01	0.01	0.01	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net Debt to EBITDA	-1.95	-4.40	-7.62	-12.02	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Long-Term Debt to EBITDA	0.23	0.01	0.01	0.01	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Debt to NOPAT	-0.15	0.08	-0.04	-0.06	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net Debt to NOPAT	1.28	-51.49	30.94	69.04	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Long-Term Debt to NOPAT	-0.15	0.08	-0.04	-0.06	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Altman Z-Score	1.64	2.11	1.96	1.46	2.15	2.58	2.76	2.64	2.46	2.64	3.06
Noncontrolling Interest Sharing Ratio	0.00%	0.08%	0.09%	0.09%	0.12%	0.10%	0.11%	0.12%	0.14%	0.13%	0.13%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	1.32	1.34	1.28	1.44	1.46	1.66	1.80	1.83	1.59	1.64	1.83
Quick Ratio	0.62	0.66	0.62	0.65	0.56	0.58	0.92	0.99	0.81	0.76	1.02
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	34	2.17	5.26	9.19	7.33	26	25	23	-0.26	0.05	-1.59
Operating Cash Flow to CapEx	290.14%	711.39%	-370.98%	1,413.46%	1,452.97%	-1,116.32%	172.00%	557.84%	829.27%	-629.23%	855.47%
Free Cash Flow to Firm to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.52	0.33	0.16	0.00	0.62	0.64	0.69	0.73	0.76	0.82	0.94
Accounts Receivable Turnover	14.47	9.09	3.98	0.00	20.09	17.02	16.79	15.13	20.20	21.32	22.53
Inventory Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fixed Asset Turnover	0.00	0.00	0.00	0.00	14.89	0.00	0.00	0.00	17.25	18.56	19.52
Accounts Payable Turnover	4.97	6.87	6.80	5.90	7.67	10.23	7.29	7.46	6.72	11.07	7.97
Days Sales Outstanding (DSO)	25.22	40.16	91.62	0.00	18.17	21.45	21.74	24.12	18.07	17.12	16.20
Days Inventory Outstanding (DIO)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Days Payable Outstanding (DPO)	73.49	53.13	53.71	61.91	47.62	35.67	50.07	48.91	54.29	32.98	45.80
Cash Conversion Cycle (CCC)	-48.27	-12.97	37.91	0.00	-29.45	-14.22	-28.33	-24.79	-36.22	-15.86	-29.60
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	-8.03	19	17	14	-11	-7.33	-8.65	-8.83	-10	-6.51	-7.31
Invested Capital Turnover	5.84	1.50	0.71	0.00	-5.41	8.79	13.23	22.73	-5.18	-8.19	-7.34
Increase / (Decrease) in Invested Capital	-32	-2.47	-6.50	-9.54	-3.14	-27	-25	-22	1.00	0.82	1.33
Enterprise Value (EV)	125	173	192	150	133	167	146	116	105	104	102
Market Capitalization	142	193	211	172	159	190	177	146	130	125	125
Book Value per Share	$1.68	$1.77	$1.55	$1.36	$1.20	$1.50	$1.52	$1.48	$1.01	$1.10	$1.11
Tangible Book Value per Share	$1.68	$0.97	$0.76	$1.08	$1.20	$1.50	$1.52	$1.48	$1.01	$1.10	$1.11
Total Capital	27	26	23	20	18	23	23	23	15	15	16
Total Debt	2.00	0.03	0.02	0.02	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Long-Term Debt	2.00	0.03	0.02	0.02	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net Debt	-17	-20	-19	-22	-26	-23	-31	-31	-24	-21	-23
Capital Expenditures (CapEx)	1.17	0.40	0.26	0.24	0.28	0.33	0.51	0.32	0.35	0.23	0.26
Debt-free, Cash-free Net Working Capital (DFCFNWC)	-8.45	-8.38	-9.27	-5.11	-3.16	5.13	-2.76	-3.26	-5.03	-2.01	-3.18
Debt-free Net Working Capital (DFNWC)	11	11	9.37	17	23	28	28	27	19	19	20
Net Working Capital (NWC)	11	11	9.37	17	23	28	28	27	19	19	20
Net Nonoperating Expense (NNE)	13	-1.25	2.35	2.82	6.90	-1.44	-0.89	-0.70	-0.25	-0.43	-0.91
Net Nonoperating Obligations (NNO)	-33	-6.80	-6.48	-6.85	-29	-30	-32	-32	-25	-22	-23
Total Depreciation and Amortization (D&A)	1.69	1.40	1.52	1.24	0.56	0.39	0.42	0.46	0.44	0.40	0.42
Debt-free, Cash-free Net Working Capital to Revenue	-17.99%	-27.16%	-65.48%	0.00%	-6.08%	9.66%	-5.16%	-5.99%	-9.16%	-3.54%	-5.43%
Debt-free Net Working Capital to Revenue	22.91%	36.57%	66.18%	0.00%	44.01%	52.82%	52.84%	50.43%	35.11%	34.29%	33.86%
Net Working Capital to Revenue	22.91%	36.57%	66.18%	0.00%	44.01%	52.82%	52.84%	50.43%	35.11%	34.29%	33.86%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	($0.75)	$0.06	($0.24)	($0.21)	($0.18)	$0.00	$0.01	$0.06	$0.06	$0.09	$0.05
Adjusted Weighted Average Basic Shares Outstanding	14.69M	14.80M	14.95M	14.96M	14.92M	0.00	15.33M	15.34M	15.13M	14.18M	14.24M
Adjusted Diluted Earnings per Share	($0.74)	$0.06	($0.24)	($0.21)	($0.17)	$0.00	$0.01	$0.06	$0.06	$0.09	$0.05
Adjusted Weighted Average Diluted Shares Outstanding	14.94M	15.01M	15.21M	15.19M	15.15M	0.00	15.40M	15.40M	15.19M	14.19M	14.25M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	14.78M	14.97M	15.00M	14.98M	15.17M	0.00	15.34M	14.87M	14.11M	14.26M	14.14M
Normalized Net Operating Profit after Tax (NOPAT)	0.82	-0.30	-1.25	-0.34	-1.22	-0.47	-0.79	0.16	0.74	0.89	-0.11
Normalized NOPAT Margin	0.00%	-2.45%	-9.87%	-2.71%	0.00%	-3.62%	-5.98%	1.16%	4.89%	6.01%	-0.74%
Pre Tax Income Margin	0.00%	-3.20%	-13.47%	-3.23%	0.00%	-3.77%	-7.37%	2.25%	6.20%	7.52%	-1.60%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
EBIT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	-0.04%	-0.07%	-0.07%	0.00%	-0.11%	0.11%	-0.17%	118.86%	389.15%	384.69%	345.83%

Financials Breakdown Chart

Key Financial Trends

JOINT Corp. (NASDAQ:JYNT) showed improved revenue and cash generation in the second quarter of 2026, but profitability remains uneven. Revenue increased to $15.2 million from $13.3 million in the restated second quarter of 2025, a gain of approximately 14%. Gross profit rose 21.0% to $12.7 million, and the gross margin improved to approximately 83.7% from 79.1%.

Operating performance also improved year over year. JOINT reported an operating loss of $369,000 in Q2 2026 compared with a $1.1 million operating loss in Q2 2025. However, results weakened sequentially from Q1 2026, when the company generated $874,000 of operating income. Marketing expense increased sharply to $4.9 million from $3.7 million in Q1, while selling, general and administrative expense also rose to $7.6 million.

Reported net income was $653,000, or $0.05 per diluted share, but continuing operations produced a $251,000 loss. The quarterly profit was primarily supported by $904,000 of income from discontinued operations, making the headline earnings figure less representative of the ongoing business.

Cash flow improved significantly in Q2. Operating cash flow was $2.2 million, compared with an outflow of $1.5 million in Q1 2026 and inflows of $868,649 and $1.8 million in the second and third quarters of 2025, respectively. After investing and financing activities, cash increased by $2.4 million during the quarter. JOINT ended Q2 with $22.2 million of cash and equivalents, plus $846,000 of restricted cash.

The balance sheet remains mixed. Total liabilities declined to $35.8 million from $42.4 million in Q1 2026, while the current ratio improved to approximately 1.8 from 1.6. Total assets declined to $51.6 million from $80.1 million in Q3 2023, reflecting the company’s divestiture and restructuring activity. Shareholders’ equity was $15.9 million, although retained earnings remained negative at $22.8 million.

Revenue growth accelerated: Q2 2026 revenue increased approximately 14% year over year and 2.4% from Q1 2026.
Gross margin expanded: Gross margin rose to approximately 83.7%, indicating that revenue growth was accompanied by improved cost economics.
Operating loss narrowed year over year: The Q2 operating loss improved to $369,000 from $1.1 million in the restated Q2 2025 period.
Operating cash flow rebounded: JOINT generated $2.2 million of operating cash flow after posting a $1.5 million outflow in Q1 2026.
Liquidity improved sequentially: Cash and restricted cash increased by approximately $1.1 million during Q2, and total current liabilities fell by roughly $6.2 million.
Share count declined: Weighted average diluted shares fell to approximately 14.2 million from 15.4 million in the restated Q2 2025 period, aided by continued share repurchases.
Divestitures are reshaping results: The company recorded $1.2 million of divestiture proceeds in Q2, while discontinued operations contributed $904,000 to net income. Future comparisons may remain difficult as the business portfolio changes.
Debt exposure appears limited: The latest balance sheet does not report long-term debt, and cash interest paid was only $12,639 in Q2.
Continuing operations remained unprofitable: The core business posted a $251,000 loss in Q2, and operating income deteriorated from Q1’s $874,000 profit.
Spending pressure remains elevated: Marketing expense increased approximately 40% from Q1 and 40% from the restated Q2 2025 period, while accumulated retained losses remain substantial.

Overall, JOINT’s recent statements point to improving revenue, margins, liquidity and operating cash flow, but investors should distinguish between continuing operations and reported net income. Sustained profitability will likely depend on whether the company can control marketing and administrative spending without relying on divestiture-related proceeds or discontinued operations to support earnings.

10/15/26 11:54 PM ETAI Generated. May Contain Errors.

Joint Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Joint's financial year ends in December. Their financial year 2025 ended on December 31, 2025.

Joint's net income appears to be on an upward trend, with a most recent value of $2.91 million in 2025, compared with -$8.80 million in 2015. The previous period was -$5.80 million in 2024. See Joint's forecast for analyst expectations on what's next for the company.

Joint's total operating income in 2025 was -$913.38 thousand, based on the following breakdown:

Total Gross Profit: $43.67 million
Total Operating Expenses: $44.58 million

Over the last 10 years, Joint's total revenue changed from $13.84 million in 2015 to $54.90 million in 2025, a change of 296.8%.

In the past 11 quarters, Joint's cash and equivalents has ranged from $16.05 million in Q3 2023 to $29.81 million in Q2 2025, and is currently $22.16 million as of their latest financial filing in Q2 2026.

Joint had total debt of $0.00 at the end of 2025, compared with none in 2024, and a 100.0% decrease since 2015.

Over the last 10 years, Joint's book value per share changed from 2.09 in 2015 to 1.01 in 2025, a change of -51.5%.

Related Companies

Financial statements for NASDAQ:JYNT last updated on 8/7/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Joint (JYNT) Financials

Financials Breakdown Chart

Key Financial Trends

Joint Financials - Frequently Asked Questions

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Joint (JYNT) Financials

Annual Income Statements for Joint

Quarterly Income Statements for Joint

Annual Cash Flow Statements for Joint

Quarterly Cash Flow Statements for Joint

Annual Balance Sheets for Joint

Quarterly Balance Sheets for Joint

Annual Metrics And Ratios for Joint

Quarterly Metrics And Ratios for Joint

Financials Breakdown Chart

Key Financial Trends

Joint Financials - Frequently Asked Questions

When does Joint's fiscal year end?

How has Joint's net income changed over the last 10 years?

What is Joint's operating income?

How has Joint's revenue changed over the last 10 years?

How much cash does Joint have?

How much debt does Joint have?

How has Joint's book value per share changed over the last 10 years?

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools